Showing results (1791-1800 of 2,326) with videos related to
Sort By:
Pageof 233
Expert Opinion on Therapeutic Targets|April 29, 2009
Inhibition of HGF/MET as therapy for malignancySanjay Naran, Xinglu Zhang, Steven J HughesExpert Opinion on Therapeutic Targets|April 29, 2009
Novel factors as therapeutic targets to treat diabetes. Focus on leptin and ghrelinRodolfo Gómez, Francisca Lago, Juan J Gómez-Reino, et al.Expert Opinion on Therapeutic Targets|April 29, 2009
Molecular switching of osteoblastogenesis versus adipogenesis: implications for targeted therapiesIchiro Takada, Alexander P Kouzmenko, Shigeaki KatoExpert Opinion on Therapeutic Targets|June 10, 2009
Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer proteinPaul Jwh Kappelle, Louwerens Zwang, Menno V Huisman, et al.Expert Opinion on Therapeutic Targets|May 22, 2009
Inflammation and the pathogenesis of age-related macular degenerationAlbert J Augustin, Janna KirchhofExpert Opinion on Therapeutic Targets|February 25, 2009
CCR9 and inflammatory bowel diseaseChristian Koenecke, Reinhold FörsterExpert Opinion on Therapeutic Targets|February 25, 2009
Lipid metabolism and Alzheimer's disease: pathways and possibilitiesUday SaxenaExpert Opinion on Therapeutic Targets|February 25, 2009
Mechanisms of tumor resistance to EGFR-targeted therapiesElizabeth A Hopper-Borge, Rochelle E Nasto, Vladimir Ratushny, et al.Expert Opinion on Therapeutic Targets|February 25, 2009
NKT cell immune responses to viral infectionMarlowe S Tessmer, Ayesha Fatima, Christophe Paget, et al.Expert Opinion on Therapeutic Targets|February 25, 2009
Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiologyJoachim Beige, Katrin Heipmann, Michael Stumvoll, et al.Pageof 233